医疗器械公司泰利福宣布了一项初步重组方案,目标为每年减少因近期资产剥离所导致的4800万至5200万美元闲置成本。该计划旨在优化公司运营结构,提升整体成本效率。
医疗器械公司泰利福宣布了一项初步重组方案,目标为每年减少因近期资产剥离所导致的4800万至5200万美元闲置成本。该计划旨在优化公司运营结构,提升整体成本效率。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.